This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)


MGuard Prime





Bioresorbable Stents


Drawbacks of Bioresorbable Polymeric Stents


Selected Bioresorbable Coronary Stents

The Absorb stent


Biotronik's Dreams stent


DESolve stent


ReZolve Stent


IDEAL stent


Other bioresorbable stents




Lesion Specific Stents

Dedicated Bifurcated Stents



Nile Pax


Stentys Self-Apposing stent


Taxus Petal


Xience Side Branch Access




Taxus Liberte Atom


Xience nano





Sales and Marketing Capabilities


Differentiation Strategies

Improved Stent Materials


Reduced DAPT Duration



Lesion-Specific Stents

Extended Indications



Significant Trends In The Coronary Stents Market



Market Drivers

New devices Expanded Indications

Acute Myocardial Infarction and Diabetes



Emerging Markets Are Expected To Spur The Overall Market Growth.



Market Restraints

Price decline hampers growth in the overall market.


Cost Constraints


Difficult Economic Conditions



Notable Recent Industry Events

Recent Mergers and Acquisitions

Biosensors International acquired CardioMind and Devax


Medtronic Acquired Invatec


Xenogenics Corporation Acquired Bioabsorbable Therapeutics



Market Exits





Market by Type of Stent

Drug Eluting Stents Market

Market Snapshot



Products Analysis

Xience V


Promus Element/Plus


Resolute Integrity


Market Dynamics in the Drug-Eluting Stents Segment




Revenue Forecast

Bare Metal Stents Market

Market Snapshot


Market Dynamics


Revenue Forecast



United States

Market Snapshot


Revenue Forecast




Market snapshot


Revenue Forecast




Market snapshot


Revenue forecast




Market Snapshot


Revenue forecast




Market snapshot


Revenue Forecast



3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs